A Clinical Practice Guideline for Treating Tobacco Use and Dependence (2008) 2008 Update. A U.S. Public Health Service Report. Am J Prev Med 35(2):158–176. https://doi.org/10.1016/j.amepre.2008.04.009

Article  Google Scholar 

Adams JM (2020) Smoking Cessation—Progress, barriers, and New opportunities: the Surgeon General’s Report on Smoking Cessation. JAMA 323(24):2470–2471. https://doi.org/10.1001/JAMA.2020.6647

Article  PubMed  Google Scholar 

Akkus F, Mihov Y, Treyer V, Ametamey SM, Johayem A, Senn S, Rösner S, Buck A, Hasler G (2018) Metabotropic glutamate receptor 5 binding in male patients with alcohol use disorder. Translational Psychiatry 2017 8:1(1):1–8. https://doi.org/10.1038/s41398-017-0066-6

Al-Hamdani M, Manly E (2021) Smoking cessation or initiation: the paradox of vaping. Prev Med Rep 22:101363. https://doi.org/10.1016/j.pmedr.2021.101363

Article  PubMed  PubMed Central  Google Scholar 

American Lung Association (2024) Health effects of secondhand smoke. Retrieved from: https://www.lung.org/quit-smoking/smoking-facts/health-effects/secondhand-smoke. Accessed 24 Dec 2024

Anton RF (2008) Naltrexone for the management of alcohol dependence. N Engl J Med 359(7):715–721. https://doi.org/10.1056/NEJMct0801733

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anton B, Leff P (2006) A novel bivalent morphine/heroin vaccine that prevents relapse to heroin addiction in rodents. Vaccine 24(16):3232–3240. https://doi.org/10.1016/J.VACCINE.2006.01.047

Article  CAS  PubMed  Google Scholar 

Anton RF, O’Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A (2006) Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 295(17):2003–2017. https://doi.org/10.1001/JAMA.295.17.2003

Article  CAS  PubMed  Google Scholar 

Aubin HJ, Luquiens A, Berlin I (2014) Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice. Br J Clin Pharmacol 77(2):324–336. https://doi.org/10.1111/BCP.12116

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bartus RT, Emerich DF, Hotz J, Blaustein M, Dean RL, Perdomo B, Basile AS (2003) Vivitrex®, an Injectable, extended-release formulation of Naltrexone, provides pharmacokinetic and pharmacodynamic evidence of efficacy for I Month in rats. Neuropsychopharmacology 28(11):1973–1982. https://doi.org/10.1038/sj.npp.1300274

Article  CAS  PubMed  Google Scholar 

Berkowitz B, Spector S (1972) Evidence for active immunity to Morphine in mice. Science 178(4067):1290–1292. https://doi.org/10.1126/SCIENCE.178.4067.1290

Article  CAS  PubMed  Google Scholar 

Biernacka JM, Coombes BJ, Batzler A, Ho AMC, Geske JR, Frank J, Hodgkinson C, Skime M, Zillich L, Pozsonyiova S, Ho MF, Kiefer F, Rietschel M, Weinshilboum R, O’Malley SS, Mann K, Anton R, Goldman D, Karpyak VM (2021) Genetic contributions to alcohol use disorder treatment outcomes: a genome-wide pharmacogenomics study. Neuropsychopharmacol 46:2132–2139. https://doi.org/10.1038/s41386-021-01097-0

Article  CAS  Google Scholar 

Bonese KF, Wainer BH, Fitch FW, Rothberg RM, Schuster CR (1974) Changes in heroin self-administration by a rhesus monkey after morphine immunisation. Nature 1974 252(5485):708–710. https://doi.org/10.1038/252708a0

Bronstein DM, Day NC, Gutstein HB, Trujillo KA, Akil H (1993) Pre- and posttranslational regulation of β‐Endorphin biosynthesis in the CNS: effects of Chronic Naltrexone Treatment. J Neurochem 60(1):40–49. https://doi.org/10.1111/j.1471-4159.1993.tb05820.x

Article  CAS  PubMed  Google Scholar 

Castaldelli-Maia JM, Bhugra D (2022) Analysis of global prevalence of mental and substance use disorders within countries: focus on sociodemographic characteristics and income levels. Int Rev Psychiatry 34(1):6–15. https://doi.org/10.1080/09540261.2022.2040450

Centers for Disease Control (2020) Smoking cessation: a report of the surgeon general. https://www.cdc.gov/tobacco-surgeon-general-reports/reports/2020-smokingcessation/index.html. Accessed 28 Oct 2024

Center for Substance Abuse Treatment (2009) Substance abuse treatment: addressing the specific needs of women. https://www.ncbi.nlm.nih.gov/books/NBK83252/. Accessed 24 Dec 2024

Cepeda-Benito A, Reynoso JT, Erath S (2004) Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: differences between men and women. J Consult Clin Psychol 72(4):712–722. https://doi.org/10.1037/0022-006X.72.4.712

Article  PubMed  Google Scholar 

Chapter 2—Acamprosate - Incorporating Alcohol Pharmacotherapies Into Medical Practice - NCBI Bookshelf (2009). https://www.ncbi.nlm.nih.gov/books/NBK64035/. Accessed 23 Dec 2024

Chiang CN, Hollister LE, Kishimoto A, Barnett G (1984) Kinetics of a naltrexone sustained-release preparation. Clin Pharmacol Ther 36(5):704–708. https://doi.org/10.1038/CLPT.1984.243

Article  CAS  PubMed  Google Scholar 

Chukwueke CC, Le Foll B (2019) The human laboratory and drug development in alcohol use disorder: recent updates. Methods Mol Biol 2011:195–219. https://doi.org/10.1007/978-1-4939-9554-7_12

Ciwun M, Tankiewicz-Kwedlo A, Pawlak D (2024) Low-dose naltrexone as an adjuvant in combined anticancer therapy. Cancers (Basel) 16(6):1240. https://doi.org/10.3390/cancers16061240

Comer SD, Sullivan MA, Yu E et al (2006) Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial. Arch Gen Psychiatry 63(10):210–218. https://doi.org/10.1001/archpsyc.63.2.210

Article  CAS  PubMed  PubMed Central  Google Scholar 

Connery HS, McHugh RK, Reilly M, Shin S, Greenfield SF (2020) Substance use disorders in global mental health delivery: epidemiology, treatment gap, and implementation of evidence-based treatments. Harv Rev Psychiatry 28(5):316–327. https://doi.org/10.1097/HRP.0000000000000271

Article  PubMed  PubMed Central  Google Scholar 

Coutureau E, Killcross S (2003) Inactivation of the infralimbic prefrontal cortex reinstates goal-directed responding in overtrained rats. Behav Brain Res 146(1–2):167–174. https://doi.org/10.1016/J.BBR.2003.09.025

Article  PubMed  Google Scholar 

Cruciani RA, Knotkova H (eds) (2013) Handbook of methadone prescribing and buprenorphine therapy. Springer, New York

Davidson J (1979) Seizures and bupropion: a review. J Clin Psychiatry 50(7):256–261

Dalley JW, Cardinal RN, Robbins TW (2004) Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev 28(7):771–784. https://doi.org/10.1016/J.NEUBIOREV.2004.09.006

Article  CAS  PubMed  Google Scholar 

Dean RL (2009) Nonclinical Pharmacology of VIVITROL®: a monthly injectable for the treatment of alcohol dependence. Opiate receptors and antagonists, Chap. 35. Humana Press

Dixon DW, Pierson RP (2023) Opioid abuse: practice essentials, background, pathophysiology. Medscape. Chief Editor: Xiong GL. https://emedicine.medscape.com/article/287790-overview#a5. Accessed 26 Dec 2024

Domingo-Rodriguez L, Ruiz de Azua I, Dominguez E, Senabre E, Serra I, Kummer S, Navandar M, Baddenhausen S, Hofmann C, Andero R, Gerber S, Navarrete M, Dierssen M, Lutz B, Martín-García E, Maldonado R (2020) A specific prelimbic-nucleus accumbens pathway controls resilience versus vulnerability to food addiction. Nat Commun 11(1):782. https://doi.org/10.1038/s41467-020-14458-y

Douaihy AB, Kelly TM, Sullivan C (2013) Medications for substance use disorders. Soc Work Public Health 28(3–4):264–278. https://doi.org/10.1080/19371918.2013.759031

Dydyk AM, Jain NK, Gupta M (2020) Opioid use disorder. In: StatPearls. StatPearls Publishing, Treasure Island (FL)

Everitt BJ, Robbins TW (2005) Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8(11):1481–1489. https://doi.org/10.1038/nn1579

Article  CAS  PubMed  Google Scholar 

Faessel H, Ravva P, Williams K (2009) Pharmacokinetics, safety, and tolerability of varenicline in healthy adolescent smokers: a multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Clin Ther 31(1):177–189. https://doi.org/10.1016/j.clinthera.2009.01.003

Ferry LH (1999) Non-nicotine pharmacotherapy for smoking cessation. Prim Care 26(3):653–669. https://doi.org/10.1016/S0095-4543(05)70122-6

Article  CAS  PubMed  Google Scholar 

Fischer G, Ortner R, Rohrmeister K, Jagsch R, Baewert A, Langer M, Aschauer H (2006) Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study. Addiction (Abingdon England) 101(2):275–281. https://doi.org/10.1111/J.1360-0443.2006.01321.X

Article  PubMed  Google Scholar 

Food and Drug Administration (2008) Vivitrol intramuscular: Highlights of prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021897s015lbl.pdf. Accessed 6 Oct October

Food and Drug Administration (2016) Chantix (varenicline) tablets, for oral use. https://www.accessdata.fda.gov/. Accessed 23 Dec 2024

Franks P, Harp J, Bell B (1989) Randomized, controlled trial of clonidine for smoking cessation in a primary care setting. JAMA 262:3011–3013

Article  CAS  PubMed  Google Scholar 

Giulietti F, Filipponi A, Rosettani G, Giordano P, Iacoacci C, Spannella F, Sarzani R (2020) Pharmacological approach to smoking cessation: an updated review for daily clinical practice. High Blood Press Cardiovasc Prev 27(5):349–362. Adis. https://doi.org/10.1007/s40292-020-00396-9

Gourlay SG, Stead LF, Benowitz NL (2004) Clonidine for smoking cessation. Cochrane Database Syst Rev 3:CD000058

Google Scholar 

Grant BF, Goldstein RB, Saha TD, Chou SP, Jung J, Zhang H, Pickering RP, Ruan WJ, Smith SM, Huang B, Hasin DS (2015) Epidemiology of DSM-5 Alcohol Use Disorder: results from the national epidemiologic survey on Alcohol and related conditions. JAMA Psychiatry 72(8):757–766. https://doi.org/10.1001/jamapsychiatry.2015.0584

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hajek P, Stead LF (2004) Aversive smoking for smoking cessation. Cochrane Database Syst Rev 2001(3):CD000546. https://doi.org/10.1002/14651858.CD000546.pub2

Article  PubMed